Patent · US Active

Chemical compounds

US8575203B2 · kind B2 · utility

7Cited by

0References

11Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Harald Engelhardt · Ebreichsdorf, AT
Christiane Kofink · Perchtoldsdorf, AT
Darryl McConnell · Wien, AT

Key dates

Filing date	Apr 19, 2011
Grant date	Nov 5, 2013
Priority date	—
Expiry date	Aug 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of general formula (1)wherein the groups R1 to R4, Qa, Qb, QH, L and n are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, pharmaceutical preparations which contain such compounds and their use as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.